FDA Clearance for clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia (CLL) This is good news for CLL patients as measurement for MRD (minimal or measurable residual disease) is increasingly being recognized... August 11, 2020Business, Finances, Insurance & Regulatory, MRD & Disease MonitoringBy Brad Hedrick
COVID-19 severity and mortality in chronic lymphocytic leukemia (CLL) patients With recent publications in two well respected and influential peer reviewed journals, BLOOD and NATURE, we are finally getting some... July 27, 2020NewsBy Brad Hedrick
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma Hopefully the next approval will be for CLL patients, but there is still much work to be done in clinical... July 27, 2020Business, Finances, Insurance & Regulatory, CAR-TBy Brad Hedrick
Telemedicine: Managing Patients with CLL During the COVID-19 Pandemic The CLL Society is fortunate to have Dr. John Pagel as a member of both our medical advisory board and... July 21, 2020NewsBy Brad Hedrick
Free translations of common terms used on relationship to COVID-19 In April, Eriksen Translations released a glossary of COVID-19 terms, to help organizations develop multilingual messaging related to the coronavirus... July 15, 2020NewsBy Brad Hedrick
CLLAN on COVID-19 The CLL Society is an active member and Dr. Koffman serves on the steering committee of CLLAN or the international... July 15, 2020NewsBy Brad Hedrick
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19 COVID-19 is an efficient killer in chronic lymphocytic leukemia (CLL) patients. While most patients recover, those who develop an exaggerated... June 15, 2020NewsBy Brad Hedrick
Living with CLL during the COVID19 Pandemic Since March 2020 when the WHO declared COVID19 a pandemic, the questions I have heard the most in my clinic... June 1, 2020NewsBy Brad Hedrick
Facebook Interview with Blood Cancers Uncensored Source: Blood Cancer Uncensored Facebook Page | Link to Facebook video interview... May 22, 2020News, Official Statements and Press Releases, Publications and ResearchBy Brad Hedrick
Proposed Changes to Reimbursement to Help Pay for CAR-T Therapy for Patients Covered by Medicare or Medicaid May 15, 2020 CAR-T is an essential new treatment opportunity for patients. In my personal experience, I have no measurable leukemia... May 18, 2020Business, Finances, Insurance & Regulatory, CAR-TBy Brad Hedrick
